Finance

Lists
NRSNW:NASDAQ
Neurosense Therapeutics Ltd
$0.010
0.00%
(0.00) 1D
Oct 15, 10:42:53 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NRSNW...
Mkt. cap
4.91M
Avg. vol.
3.50K
Volume
6.00
52-wk high
$0.54
52-wk low
$0.00
Beta
4.97
No. of employees
17
Mkt. cap
4.91M
Avg. vol.
3.50K
Volume
6.00
52-wk high
$0.54
52-wk low
$0.00
Beta
4.97
No. of employees
17
News stories
From web sources and news partners
About Neurosense Therapeutics Ltd
CEO-
Employees17
Founded2017
Headquarters-
SectorBiotechnology
Websiteneurosense-tx.com
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.25M
1.25M
1.86M
1.86M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.09M
1.09M
1.33M
1.33M
Operating expense
2.35M
2.35M
3.20M
3.20M
Total operating expenses
2.35M
2.35M
3.20M
3.20M
Operating income
-2.35M
-2.35M
-3.20M
-3.20M
Other non operating income
-
-
-3.00K
-3.00K
EBT including unusual items
-2.35M
-2.35M
-3.21M
-3.21M
EBT excluding unusual items
-2.35M
-2.35M
-3.21M
-3.21M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.35M
-2.35M
-3.21M
-3.21M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
15.00K
15.00K
Interest expense
-8.50K
-8.50K
-
-
Net interest expenses
-8.50K
-8.50K
15.00K
15.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.34M
-2.34M
-3.19M
-3.19M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps